Why the study?
Does apheretic treatment (plasmapheresis or cascade filtration) reduce triglyceride levels in patients with hypertriglyceridemia receiving Cyclosporin A after bone marrow transplantation?
Population
15 patients with hypertriglyceridemia complicating their course while receiving Cyclosporin A after bone…
Design
Case_series
Authors
Loading...
Apheresis may reduce triglycerides in cyclosporine-associated hypertriglyceridemia post-BMT; leaves open comparative efficacy and outcomes versus medical therapy.
Does apheretic treatment (plasmapheresis or cascade filtration) reduce triglyceride levels in patients with hypertriglyceridemia receiving Cyclosporin A after bone marrow transplantation?
Plasmapheresis and cascade filtration can remove triglycerides in patients with severe hypertriglyceridemia following bone marrow transplantation, though filter saturation may limit efficacy.
Giannini et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: